2015•Guoji zhongliuxue zazhiRequires access

10.3760/cma.j.issn.1673-422X.2015.04.019

Sheng-Neng-Quan- Yang-Yi- Wang-Zhi-Gang

Open publisher page 0 citations

Abstract

Gastrointestinal neuroendocrine tumor (GI-NET) originates from peptide neurons and neuroendocrine cells in gastrointestinal tract, and secrets peptide hormones, leading to carcinoid syndrome which rarely happens in clinical practice. Because of the improvement of diagnostic method and understanding of this rare disease, the morbidity is rising in recent years. The main treatments of GI-NET are surgery and comprehensive therapy, consisting of chemotherapy and targeted therapy. Key words: Gastrointestinal tract; Neuroendocrine tumors; Diagnostic evaluation; Therapeutics

About this research paper

What this paper is about

Gastrointestinal neuroendocrine tumor (GI-NET) originates from peptide neurons and neuroendocrine cells in gastrointestinal tract, and secrets peptide hormones, leading to carcinoid syndrome which rarely happens in clinical practice. Because of the improvement of diagnostic method and understanding of this rare disease, the morbidity is rising in recent years. The main treatments of GI-NET are surgery and comprehensive therapy, consisting of chemotherapy and targeted therapy. Key words: Gastrointestinal tract; Neuroendocrine tumors; Diagnostic evaluation; Therapeutics

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Gastrointestinal neuroendocrine tumor (GI-NET) originates from peptide neurons and neuroendocrine cells in gastrointestinal tract, and secrets peptide hormones, leading to carcinoid syndrome which rarely happens in clinical practice. Because of the improvement of diagnostic method and understanding of this rare disease, the morbidity is rising in recent years. The main treatments of GI-NET are surgery and comprehensive therapy, consisting of chemotherapy and targeted therapy. Key words: Gastrointestinal tract; Neuroendocrine tumors; Diagnostic evaluation; Therapeutics

Key concepts: Neuroendocrine tumors, Gastrointestinal tract, Carcinoid syndrome, Medicine, Digestive tract, Disease, Chemotherapy, Octreotide

Related papers

Back to paper searchBrowse research topicsOriginal source
10.3760/cma.j.issn.1673-422X.2015.04.019 — Research Paper | ScholarLens